Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Shares Issued (2017 - 2025)

Ocugen's Shares Issued history spans 11 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 55.76% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $2.4 million, up 150.53%, while the annual FY2025 figure was $19.9 million, 48.51% down from the prior year.
  • Shares Issued reached $1.5 million in Q4 2025 per OCGN's latest filing, up from $981000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $100.4 million in Q2 2021 to a low of -$128.0 million in Q4 2021.
  • Average Shares Issued over 5 years is $5.6 million, with a median of $981000.0 recorded in 2024.
  • The largest YoY upside for Shares Issued was 6031.25% in 2024 against a maximum downside of 102.53% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$128.0 million in 2021, then soared by 106.58% to $8.4 million in 2022, then crashed by 99.81% to $16000.0 in 2023, then surged by 6031.25% to $981000.0 in 2024, then surged by 55.76% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for OCGN's Shares Issued are $1.5 million (Q4 2025), $981000.0 (Q4 2024), and -$145000.0 (Q1 2024).